Mirae Asset Global Investments
LFCR icon

Mirae Asset Global Investments’s Lifecore Biomedical LFCR Stock Holding History

Mirae Asset Global Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81K Sell
1,678
-276
-14% -$1.39K ﹤0.01% 1584
2026
Q1 		$7.27K Buy
1,954
+133
+7% +$918 ﹤0.01% 1518
2025
Q4 		$14.9K Buy
+1,821
New +$13.5K ﹤0.01% 1573
2024
Q2 		– Sell
-10,860
Closed -$36.1K – 2078
2024
Q1 		$36.1K Buy
+10,860
New +$77.7K ﹤0.01% 2431
2023
Q2 		– Sell
-10,860
Closed -$41K – 2656
2023
Q1 		$41K Hold
10,860
– – ﹤0.01% 2517
2022
Q4 		$70.4K Hold
10,860
– – ﹤0.01% 2498
2022
Q3 		$97K Buy
+10,860
New +$110K ﹤0.01% 2508

Other funds holding LFCR

CA
CWC Advisors Lake Oswego, Oregon $225M AUM 23.94% 1-Year Est. Return
DT
DBA Trading Fort Lauderdale, Florida $199M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
UIA
Ulland Investment Advisors Minneapolis, Minnesota $136M AUM 32.68% 1-Year Est. Return

Mirae Asset Global Investments's LFCR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Lifecore Biomedical (LFCR) stake by 14% in Q2 2026, selling an estimated $1.39K and leaving 1,678 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Mirae Asset Global Investments first reported a position in LFCR in Q3 2022 and has held it in 7 quarters since. The position peaked at $97K in Q3 2022. 17 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Mirae Asset Global Investments held 1,678 shares of Lifecore Biomedical worth $8.81K as of Q2 2026.
  • Mirae Asset Global Investments sold 276 Lifecore Biomedical shares in Q2 2026, an estimated $1.39K.
  • Lifecore Biomedical made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1584 holding.
  • Mirae Asset Global Investments first reported a position in Lifecore Biomedical in Q3 2022 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Lifecore Biomedical position peaked at $97K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.